FTC backs down in pharma battle

Wednesday, 25 January 2012

Lundbeck purchased NeoProfen in 2006
The US Federal Trade Commission (FTC) has announced it will not seek a Supreme Court judgment on its monopolisation case against pharmaceutical company Lundbeck, marking the end of a protracted antitrust battle.

DG Comp opens investigation into Lundbeck

Premium Article - Friday, 08 January 2010

The European Commission yesterday launched an inquiry of Danish pharmaceutical company Lundbeck on suspicion of abusing its dominant position in the generic drug market.

DG Comp targets more pharma companies

Premium Article - Thursday, 10 December 2009

The European Commission yesterday raided several pharmaceutical companies on suspicion of competition infringements.

Back to top

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK
Queen's Award logo International Bar Association logo American Bar Association strategic partner logo

Copyright © 2012 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 207 908 1188 / Fax: +44 207 229 6910

http://www.globalcompetitionreview.com | editorial@globalcompetitionreview.com